Anti-Osteoglycin (OGN) Polyclonal Antibody 
OIF; SLRR3A; Mimecan Proteoglycan; Osteoinductive Factor
Overview
Properties
- Product No.FAC688Ra01
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- ApplicationsFCM
Research use only - Downloadn/a
- CategoryMetabolic pathway
- Ig Type IgG, Potency n/a
- PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
- LabelNone
- Excitation Laser
- Vol. per test
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- TraitsLiquid
Share your citation
Upload your experimental result
Review
Leave a message
Loading...
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Please attach serial No. on instruction manual
Contact us
Please fill in the blank.
Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code*
-
Packages (Simulation)
-
Packages (Simulation)
-
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-rat OGN Polyclonal Antibody (Catalog FAC688Ra01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
-
ISO9001: 2008, ISO13485: 2003 Registered
Usage
Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Giveaways
Increment services
-
Protein A/G Purification Column
-
Positive Control for Antibody
-
Tissue/Sections Customized Service
-
Phosphorylated Antibody Customized Service
-
Flow Cytometry (FCM) Experiment Service
-
Immunoprecipitation (IP) Experiment Service
-
Immunofluorescence (IF) Experiment Service
-
Buffer
-
DAB Chromogen Kit
-
SABC Kit
-
Isotype Control
-
Real Time PCR Experimental Service
Citations
- Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.pubmed:27836731
- Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.pubmed:28824047
- Osteoglycin, a novel coordinator of bone and glucose homeostasisPubmed:29799418
- Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathwayPubmed:29499765
- Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patientsPubmed:29867136
- Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose TissuePubmed: 30332637
- Osteoglycin across the adult lifespan34850904